BARON HOOD: Open Payments
NPI 1851750582 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,441 in 57 payments from 9 companies in 2025. Trend: 2023 $1,219 · 2024 $2,687 · 2025 $1,441
Food & beverage: $1,441
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 22 | $500 |
| Gilead Sciences, Inc. | 15 | $443 |
| Novo Nordisk Inc | 5 | $193 |
| Merck Sharp & Dohme LLC | 5 | $118 |
| Theratechnologies Inc. | 4 | $83 |
| Verity Pharmaceuticals Inc. | 3 | $51 |
| Abbott Laboratories | 1 | $22 |
| Exact Sciences Corporation | 1 | $16 |
| EMD Serono, Inc. | 1 | $16 |
Products named: CABENUVA, Wegovy, APRETUDE, DOVATO, PIFELTRO, EGRIFTA, Tlando, RUKOBIA.
Industry payments across GA — which companies pay providers there.
